An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac) in the treatment of recurrent respiratory tract infections in Thai patients.

Jareoncharsri, Perapun; Bunnag, Chaweewan; Tunsuriyawong, Prayuth; Assanasane, Paraya; Voraprayoon, Siriporn; Pinkaew, Bangon

Jareoncharsri, Perapun; Bunnag, Chaweewan; Tunsuriyawong, Prayuth; Assanasane, Paraya; Voraprayoon, Siriporn; Pinkaew, Bangon.

Asian Pac J Allergy Immunol ; 2003 Dec; 21(4): 223-30

Article in En | IMSEAR | ID: sea-37050

Subject(s)

Administration, Oral; Adolescent; Adult; Aged; Bacterial Vaccines/administration & dosage; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Respiratory Tract Infections/drug therapy; Thailand; Treatment Outcome

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Recurrence / Respiratory Tract Infections / Thailand / Aged / Female / Humans / Male / Bacterial Vaccines / Child / Child, Preschool Type of study: Observational_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Journal: Asian Pac J Allergy Immunol Year: 2003 Type: Article

Fulltext

Add to My VHL

XML

Search on Google